Summer Street Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Summer Street. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Summer Street. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrials Medical Miscellaneous Multi-Sector Conglomerates Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsNTLAIntellia Therapeutics$11.95+3.6%10/27/2020Initiated bySummer Street-BuyHighView details for Summer Street rating of Intellia Therapeutics (NASDAQ:NTLA) on 10/27/2020AMDAdvanced Micro Devices$146.24-0.1%1/29/2020Upgraded bySummer Street-Neutral -> BuyHighView details for Summer Street rating of Advanced Micro Devices (NASDAQ:AMD) on 1/29/2020EBSEmergent Biosolutions$7.28-1.1%3/6/2015Reiterated bySummer Street-Buy$35.00N/AView details for Summer Street rating of Emergent Biosolutions (NYSE:EBS) on 3/6/2015RMTIRockwell Medical$1.11-1.8%1/27/2015Target Set bySummer StreetAnalyst James MolloyPositive -> Buy$275.00N/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 1/27/2015RMTIRockwell Medical$1.11-1.8%11/4/2014Reiterated bySummer StreetAnalyst James MolloyPositiveN/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/4/2014RMTIRockwell Medical$1.11-1.8%9/12/2014Reiterated bySummer StreetAnalyst James MolloyBuyN/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/12/2014SNNSmith & Nephew SNATS$30.06-0.7%6/5/2014Target Raised bySummer Street-Buy$100.00 -> $112.00N/AView details for Summer Street rating of Smith & Nephew SNATS (NYSE:SNN) on 6/5/2014IONSIonis Pharmaceuticals$42.55+2.0%5/23/2014Reiterated bySummer Street-NeutralN/AView details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/23/2014ZBHZimmer Biomet$93.795/19/2014Upgraded bySummer Street-Neutral -> Buy$133.00N/AView details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 5/19/2014EBSEmergent Biosolutions$7.28-1.1%5/15/2014Initiated bySummer Street-Buy$35.00N/AView details for Summer Street rating of Emergent Biosolutions (NYSE:EBS) on 5/15/2014 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BMYBristol Myers Squibb$47.36+1.1%4/25/2014Target Lowered bySummer Street-Buy$102.50 -> $92.00N/AView details for Summer Street rating of Bristol Myers Squibb (NYSE:BMY) on 4/25/2014AVDLAvadel Pharmaceuticals$10.04+4.5%4/9/2014Initiated bySummer Street-Positive -> Buy$25.00N/AView details for Summer Street rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/9/2014BMYBristol Myers Squibb$47.36+1.1%3/19/2014Target Raised bySummer Street-Buy$90.00 -> $102.50N/AView details for Summer Street rating of Bristol Myers Squibb (NYSE:BMY) on 3/19/2014NWBONorthwest Biotherapeutics$0.27+16.5%3/11/2014Target Raised bySummer Street-Buy$10.33 -> $15.10N/AView details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 3/11/2014ANIKAnika Therapeutics$11.53+2.3%2/26/2014Target Raised bySummer Street-Buy$47.00 -> $60.00N/AView details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 2/26/2014LGNDLigand Pharmaceuticals$126.92+4.3%2/24/2014Target Raised bySummer Street-Buy$78.00 -> $91.00N/AView details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 2/24/2014SNNSmith & Nephew SNATS$30.06-0.7%2/24/2014Target Raised bySummer Street-Buy$80.00 -> $83.00N/AView details for Summer Street rating of Smith & Nephew SNATS (NYSE:SNN) on 2/24/2014RMTIRockwell Medical$1.11-1.8%2/13/2014Reiterated bySummer Street-BuyN/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 2/13/2014GILDGilead Sciences$112.09+2.2%2/5/2014Reiterated bySummer Street-BuyN/AView details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 2/5/2014LGNDLigand Pharmaceuticals$126.92+4.3%1/27/2014Target Raised bySummer Street-Buy$69.00 -> $78.00N/AView details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/27/2014LGNDLigand Pharmaceuticals$126.92+4.3%11/22/2013Target Raised bySummer Street-$69.00N/AView details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 11/22/2013RMTIRockwell Medical$1.11-1.8%11/6/2013Reiterated bySummer Street-Buy$275.00N/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/6/2013ANIKAnika Therapeutics$11.53+2.3%11/1/2013Target Raised bySummer Street-Buy$28.00 -> $35.00N/AView details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 11/1/2013VRTXVertex Pharmaceuticals$472.35+0.7%10/30/2013Downgraded bySummer Street-Buy -> NeutralN/AView details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/30/2013NWBONorthwest Biotherapeutics$0.27+16.5%9/19/2013Initiated bySummer Street-Buy$10.33N/AView details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 9/19/2013EXASExact Sciences$54.30+4.6%9/16/2013Initiated bySummer Street-BuyN/AView details for Summer Street rating of Exact Sciences (NASDAQ:EXAS) on 9/16/2013RMTIRockwell Medical$1.11-1.8%9/5/2013Target Raised bySummer Street-Buy$220.00 -> $275.00N/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/5/2013AMGNAmgen$297.03+0.6%8/26/2013Downgraded bySummer Street-NeutralN/AView details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/26/2013RMTIRockwell Medical$1.11-1.8%8/2/2013Reiterated bySummer Street-Buy$220.00N/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 8/2/2013LGNDLigand Pharmaceuticals$126.92+4.3%8/2/2013Target Raised bySummer Street-Buy$36.00 -> $64.00N/AView details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 8/2/2013ANIKAnika Therapeutics$11.53+2.3%8/2/2013Target Raised bySummer Street-Buy$20.00 -> $28.00N/AView details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 8/2/2013ZBHZimmer Biomet$93.791/30/2013Downgraded bySummer Street-Buy -> NeutralN/AView details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 1/30/2013BMYBristol Myers Squibb$47.36+1.1%1/23/2013Target Raised bySummer Street-Buy$41.50 -> $61.00N/AView details for Summer Street rating of Bristol Myers Squibb (NYSE:BMY) on 1/23/2013PBYIPuma Biotechnology$3.45+1.8%11/15/2012Downgraded bySummer Street-NeutralN/AView details for Summer Street rating of Puma Biotechnology (NASDAQ:PBYI) on 11/15/2012BMRNBioMarin Pharmaceutical$58.23+0.2%11/6/2012Target Raised bySummer Street-Buy$52.00 -> $69.00N/AView details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/6/2012UTHRUnited Therapeutics$297.68+0.7%10/24/2012Downgraded bySummer Street-Buy -> NeutralN/AView details for Summer Street rating of United Therapeutics (NASDAQ:UTHR) on 10/24/2012IONSIonis Pharmaceuticals$42.55+2.0%10/17/2012Downgraded bySummer Street-Buy -> NeutralN/AView details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/17/2012BMRNBioMarin Pharmaceutical$58.23+0.2%9/28/2012Target Raised bySummer Street-Buy$45.00 -> $52.00N/AView details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/28/2012VRTXVertex Pharmaceuticals$472.35+0.7%5/8/2012Reiterated bySummer Street-BuyN/AView details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/8/2012RMTIRockwell Medical$1.11-1.8%4/11/2012Initiated bySummer Street-Buy$220.00N/AView details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 4/11/2012Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see whyCRISCuris$1.88+2.7%1/31/2012Target Raised bySummer Street-Buy$500.00 -> $700.00N/AView details for Summer Street rating of Curis (NASDAQ:CRIS) on 1/31/2012LGNDLigand Pharmaceuticals$126.92+4.3%1/13/2012Initiated bySummer Street-Buy$22.00N/AView details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/13/2012GILDGilead Sciences$112.09+2.2%11/22/2011Downgraded bySummer Street-Buy -> NeutralN/AView details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 11/22/2011BMRNBioMarin Pharmaceutical$58.23+0.2%10/31/2011Target Raised bySummer Street-Buy$32.00 -> $40.00N/AView details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/31/2011BMYBristol Myers Squibb$47.36+1.1%10/28/2011Target Raised bySummer Street-$44.50N/AView details for Summer Street rating of Bristol Myers Squibb (NYSE:BMY) on 10/28/2011CRISCuris$1.88+2.7%10/6/2011Initiated bySummer Street-Buy$500.00N/AView details for Summer Street rating of Curis (NASDAQ:CRIS) on 10/6/2011ANIKAnika Therapeutics$11.53+2.3%9/19/2011Initiated bySummer Street-BuyN/AView details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 9/19/2011ATECAlphatec$10.91-0.7%9/19/2011Initiated bySummer Street-BuyN/AView details for Summer Street rating of Alphatec (NASDAQ:ATEC) on 9/19/2011AMGNAmgen$297.03+0.6%8/23/2011Initiated bySummer Street-Buy$49.00N/AView details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/23/2011BMYBristol Myers Squibb$47.36+1.1%8/17/2011Target Raised bySummer Street-Buy$33.50 -> $35.50N/AView details for Summer Street rating of Bristol Myers Squibb (NYSE:BMY) on 8/17/2011GILDGilead Sciences$112.09+2.2%8/16/2011Target Raised bySummer Street-Buy$42.00 -> $54.00N/AView details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 8/16/2011VRTXVertex Pharmaceuticals$472.35+0.7%5/24/2011Target Raised bySummer Street-Buy$46.00 -> $72.00N/AView details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/24/2011 MarketBeat Community Rating for Summer StreetCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 49,362 (Thanks for Voting!)Underperform Votes: 46,607 (Thanks for Voting!)Total Votes: 95,969MarketBeat's community ratings are surveys of what our community members think about Summer Street and other research firms. Vote "Outperform" if you believe Summer Street's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Summer Street's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
